This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Vision-Sciences Launches Authorized Repair Center For Europe

Stocks in this article: VSCI

ORANGEBURG, N.Y., Dec. 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath ® technology, today announced the full launch of the Company's official and authorized fiber and video endoscope repair center for Europe through an exclusive agreement with Rescope, a Netherlands-based facility dedicated to the technical management and repair of endoscopes.

"With our rapid growth and success in Europe, it is no longer feasible to service and manage our overseas clients from the U.S. This exclusive agreement with Rescope, a reliable and well-recognized professional repair partner, ensures we are able to cost-effectively meet the needs of our growing European customer base, expediting repairs while ensuring quality control," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences. "Our expanded centrally-located service facility will provide front-and-center expert service to our European customers, while supporting our current network of 22 distributors in 16 countries and enabling our future expansion on the continent."

Under the terms of the three-year agreement, which commenced in December 2011, Rescope is now authorized to repair the full line of Vision-Sciences endoscopes, the 4000 Series of fiber optic flexible endoscopes and the 5000 Series of video flexible endoscopes, using Vision-Sciences-certified manufacturer's parts, processes and quality standards.  Rescope is ISO 9001 certified and recently completed a nine-month infrastructure building, training and validation period before becoming fully authorized by Vision-Sciences.

"We are excited to partner with Vision-Sciences," said Petra Benink, Managing Director, Rescope, a company with nearly 20 years in the repair business that meets the most stringent safety requirements. "Our companies share a dedication to quality and customer service, and we look forward to offering excellent service to Vision-Sciences' clients in Europe."

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath ® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety.  Information about Vision-Sciences' products is available at www.visionsciences.com .

Vision-Sciences owns the trademarks Vision Sciences™ and Slide-On™ and the registered trademarks EndoSheath ®, EndoWipe ® and The Vision System ®.

About Rescope

More information about Rescope, based in Nijmegen, the Netherlands, can be found at: www.rescope.nl .

CONTACT: Keith Darragh
         VP, Finance
         Vision-Sciences, Inc.
         (845) 365-0600
         invest@visionsciences.com
         
         Lisa Wilson
         President
         In-Site Communications, Inc.
         (212) 452-2793
         lwilson@insitecony.com

company logo

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,366.11 +297.24 1.74%
S&P 500 2,009.57 +36.83 1.87%
NASDAQ 4,635.0470 +87.2130 1.92%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs